期刊文献+

阿立哌唑在儿童精神障碍中的应用 被引量:6

在线阅读 下载PDF
导出
摘要 阿立哌唑是一种多巴胺D2和5-HT1A受体的部分激动剂,同时也是5-HT2A受体的拮抗剂。临床试验数据显示,阿立哌唑能够有效治疗儿童期精神分裂症、双相障碍、抽动障碍、破坏性行为障碍以及孤独症相关行为障碍。阿立哌唑在治疗儿童患者过程中的主要不良反应为锥体外系症状(EPS)、静坐不能和镇静等;对于心电图检查结果中的QTC间期不会产生任何影响;阿立哌唑对体重或者体重指数影响很轻微;对血糖或脂质代谢没有显著改变;可使血泌乳素水平降低。因此,对于一些使用当前抗精神病药物疗效不佳或者出现显著代谢不良影响的儿童以及青少年患者,阿立哌唑可以作为一种重要的替代治疗药物。
作者 周天红 孙凌
机构地区 天津市安定医院
出处 《天津药学》 2011年第2期59-63,共5页 Tianjin Pharmacy
  • 相关文献

参考文献22

  • 1张鸿燕,马弘.阿立哌唑[J].中国新药杂志,2003,12(10):868-869. 被引量:103
  • 2Finding R L,Robb A,Nyilas M,et al.A multiple-center,randomized,double-blind placebocontrolled study of oral aripiprazole for treatment of adolescents with schizophrenia.American Journal of Psychiatry,2008,165(11):1432.
  • 3Biederman J,Mick E,Spencer T,et al.An open-label trial of aripiprazole monotherapy in children and adolescents with bipolar disorder.CNS Spectrum,2007,12(9):683.
  • 4Seo W S,Sung H M,Sea H S,et al.Aripiprazole treatment of children and adolescents with Tourette disorder or chronic tic disorder.Journal of Child and Adolescent Psychopharmacology,2008,18(2):197.
  • 5Yoo H K,Kim J Y,Kim C Y.A pilot study of aripiprazole in children and adolescents with Tourette' s disorder.Journal of Children and adolescent Psychopharmacology,2006,16(4):505.
  • 6Miranda C M,Castiglioni T C.Aripiprazole for the treatment of Tourette symdrome.Experience in 10 patients.Revista Medica de Chile,2007,135(6):773.
  • 7Budman C,Coffey B J,Shechter R,et al.Aripiprazole in children and adolescents with Tourette disorder with and without explosive outbursts.Journal of Child and Adolescent Psychopharmacology,2008,18(5):509.
  • 8梁月竹,周福春,郑毅,杨建虹,刘杰,王鹏,戚艳杰,陈旭,周玉明.阿立哌唑治疗抽动障碍的临床研究[J].精神医学杂志,2010,23(1):34-35. 被引量:17
  • 9Stigler K A,Diener J T,Kohn A E,et al.Aripiprazole in Pervasive Developmental Disorder Not Otherwise Specified and Asperger'8Disorder.A 14-Week,Prospective,Open-Label Study.Journal of Child and Adolescent Psychopharmacology,2009,19(3):265.
  • 10Bastiaens L.Anon-randomized,open study with aripiprazole and ziprasidone for the treatment of aggressive behavior in youth in a community clinic.Community Mental Health Journal,2009,45(1):73.

二级参考文献17

  • 1童建明,杨正春.几种新型抗精神病药介绍[J].临床精神医学杂志,2005,15(3):182-182. 被引量:147
  • 2Jordan S, Kopriviea V, Chen R, et al, The antipsyehotic aripiprazole is a potent, partial agonist at the human 5-HT1A reeeptor[J].Eur J Pharmacol, 2002, (441 ) : 137 - 140.
  • 3Hirose T, Uwahodo Y, Yamada S, et al. Efficacy and favorable side-effect profile of aripiprazole determined in rat with apomorphine-induced stereotype, catalepsy, and ptosis induction [ J ]. Int J Neuropsychopharm, 2000,3 (Suppl) :S131 - S136.
  • 4Burris KD, Molski TF, Ryan E, et al. Aripiprazole is a high affinity partial agonist at human D2 doparnine receptors[J]. Int J Neuropsychopharm ,2000,3(Suppl) :S129 - S130.
  • 5Jordan S, Kopriviea V, Chen R, et al. The antipsyehotie aripiprazole is a potent partial agonist at the human 5-HTIA receptors[J]. Eur Neuropsychopharm, 2001,11 (Suppl 3) :S268 - S273.
  • 6Petrie J L, Saha AR, McEvoy JP, Aripiprasole, a new antipsychotic: phase Ⅱ clinical trial result [J ]. Eur Neuropsychopharm,1997,7(Suppl 2) :S227 - S230.
  • 7Daniel DG,Saha AR, Ingenito G, et al. Aripiprazole,a novel antipsyehotie:overview of a phase Ⅱ study result[J]. Int J Neuropsychopharm, 2000,3 (Suppl 1 ) : S157 - S160.
  • 8Kane J, Ingenito G, All M. Efficacy of aripiprazole in psychotic disorders: comparison with haloperidol and placebo [J ]. Int J Neuropsychopharm, 2000,3 (Suppl 1 ) : S124 - S128.
  • 9Carson WH, Kane J, Ali M, et al. Efficacy of aripiprazole in psychotic disorders: comparison with haloperidol and placebo[J]. Int J Neuropsychopharm, 2000,10 (Suppl 3) : S309 - S312.
  • 10Saha AR,Carson WH,Ali MW,et al. Efficacy and safety of aripiprazole and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder[J]. WJ Biol Psychiat ,2001,2(Suppl1) : S305 - S308.

共引文献129

同被引文献75

引证文献6

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部